Piotr Krysiak
Research Subjects
Research Interests
Piotr Krysiak has a total of 10 co-authors. Here are the top co-authors by number of shared publications:
- David W. Denning
Manchester Fungal Infection Group, Faculty of Biology, Medicine and Health, The University of Manchester, Manchester, UK
1 shared publication - Kandadai S. Rammohan
Department of Cardiothoracic Surgery, University Hospital of South Manchester, Manchester, UK
1 shared publication - Malcolm D. Richardson
Mycology Reference Centre Manchester, ECMM Excellence Centre of Medical Mycology, Manchester University NHS Foundation Trust, Manchester, UK
1 shared publication - Mark Jones
Department of Thoracic Surgery, University Hospital of South Manchester, Manchester, UK
1 shared publication - Matthew Kneale
National Aspergillosis Centre, University Hospital of South Manchester, The University of Manchester, Manchester Academic Health Science Centre, Manchester, UK
1 shared publication - Mohan P. Devbhandari
Department of Thoracic Surgery, University Hospital of South Manchester, Manchester, UK
1 shared publication
Latest Publications
- Open Access
- 5 August 2013
- Published by Springer Nature in Journal of Cardiothoracic Surgery
- Vol. 8 (1) , 180
Results of surgery for chronic pulmonary Aspergillosis, optimal antifungal therapy and proposed high risk factors for recurrence - a National Centre’s experience
Surgery for pulmonary aspergillosis is infrequent and often challenging. Risk assessment is imprecise and new antifungals may ameliorate some surgical risks. We evaluated the medical and surgical management of these patients, including perioperative and postoperative antifungal therapy.
- 5 August 2013
- Published by Springer Nature in Journal of Cardiothoracic Surgery
- Vol. 8 (1) , 180
Open AccessResults of surgery for chronic pulmonary Aspergillosis, optimal antifungal therapy and proposed high risk factors for recurrence - a National Centre’s experience
Surgery for pulmonary aspergillosis is infrequent and often challenging. Risk assessment is imprecise and new antifungals may ameliorate some surgical risks. We evaluated the medical and surgical management of these patients, including perioperative and postoperative antifungal therapy.